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1. Introduction

Biomarkers used fo r clinical testing of certa in types of can
cer are specific proteins such as prostate-specific antigen (PSA)
(for prostate cancer). carcinoma antigen 125 (eA 125) (for ovarian cancer), cancer antigen 15-3 (eA 15-3) (for breast cancer),

and carcinoembryonic antigen (CEA) (for colon cancer ). Devel
opment of sensitive detection techniques for the detection of
low-concentration cancer biomark€'rs present in the early stage of
thedisease is crucial for the outcome ofthe treatment ofthe disease
(Rasooly and Jacobson, 2006; Warsinke, 2009), Electrochemical
imm unosensors appear to be a suitable platform for establishing
biomarker detectio n techniques (Wang, 2006). In particular, since
they allow fast real-time measurements and device miniaturiza
tion. electrochemical immunosensors are potentially suitable for
the point-oF-care approach to bioma rker assay (Warsinke, 2009).
Recent development in the detection of biomarkers includes
several noted works. In a bio-barcode assay for PSA (Thaxton
et .11.. 2009). gold nanoparticles. functionalized with DNA and PSA
specific antibodies. were used to interact through immuno-reaction
with magnetic microparticles that had been first functionalized
with PSA- specific antibodies and subsequently mixed with the
serum sample contai ning the PSA target. Afte r magnetic sep
aration, the PSA-specific DNA barcodes were released into a
solution and detected using scanometric assay. The detection

limit of this bio-barcode PSA assay was 330fg/ml serum. An
ampe rometric immunosensor for t he simultaneous detection of
two cancer biomarkers has been constructed on two iridium
oxide electrodes ( I-mm diamete r) patterned on a g lass sub
strate (Wilson. 2005). Capture antibodies were immobilized on
the porous iridium oxide electrodes by covalent attachment using
(3-aminopropyl) triethoxysilane and glutaraldehyde. The spa
tial separation of the electrodes (2.5 mm) e nabled simultaneous
electrochemical imm unoassays ofCEA and o:-fetoprotein to be con
ducted without cross-talk between the electrodes. The biomarkers
were measured using electrochemica l ELISA, and detection was
achieved by e lect rochemically oxidizing al kaline phosphatase
generated hydroq uinone. The sensor had detection li mits of 1.2,
and I nglml for CEA and o:-fetoprotein. respectively. A novel CA
125 immunosensor was prepared by co-immobilization orCA 125
and thionine, whic h was used as a n electron transfer mediator, on
a modified carbon electrode (Wu et aI., 2007). Antibodies labeled
with horseradish peroxidase (HRP) were used to bind CA 125 via
immuno-conjugation. Hydrogen peroxide (HzOz), the substrate of
HRP, was released to the sensor, and CA 125 was detected by mea
suring the electrode current prod uced due to the HRP-catalyzed
reduc tion of H20 2. The sensor showed a linear range of 2-75 U/m l
and a detection limit of 1.8 U/ml.
Recently, a novel field -effect enzymatic detec tion (FEED) tech
nique, in which an externa l gating voltage was used to induce an
electric field at the enzyme-electrode interface to amplify the sig
na l current of an enzyme-based biosensor, has been developed
(Choi and Vau, 2009). This technique was used to lower the detec
tion limit of molecula r a nalytes from t he milli-molar (10- 3 M)
level obtained in the a bsence of the gating voltage down to the
pico-molar (10- 12 M) level achieved when the gating voltage was

Fig. 1. A cross-sectional view of the detection system. The PG electrode with the
multilayers of materials deposited on it depicts the structure of the detecting electrode. The gating electrodes are represented by the circular structures, which consist
of a copper wire (the blue circles) and a thin layer of insulator (the shaded shells
made of enamel). The gating voltage VG is used to induce an electric ﬁeld at the interface between the sample solution and the detecting electrode. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version
of the article.)

applied. Compared to the conventional ﬁeld-effect-transistor (FET)
biosensor, which employs the FET to provide a reference current,
the FEED technique features a voltage-controlled ampliﬁcation of
the signal current. The signal current is produced by quantum
tunneling of electrons, which depends critically on the distance
electrons travel by means of tunneling and the potential energy
proﬁle of the tunnel structure. The FEED technique allows the
energy proﬁle of the tunnel structure to be changed using the gating voltage to increase the electron transfer rate. Therefore, the
main advantage of the new technique is the voltage-controlled
ampliﬁcation of the signal current. In the work reported here,
the FEED technique was applied to the enzyme-linked amperometric immuno-sensing scheme and the feasibility of using this
new detection approach as a biomarker detection technique was
demonstrated by the detection of the biomarker CA 125, using electrodes modiﬁed with carbon nanotube. The incorporation of the
two detection methods has resulted in a reagentless assay approach
(Wang, 2005; Weiss et al., 2007), another advantage of the reported
technique, which does not use electron transfer mediators and the
substrate of the enzyme used to label the secondary antibody. As
the result of the signal ampliﬁcation, the detection limit of the
detection system was lowered from 4.9 U/ml to 0.9 U/ml.
2. Materials and methods
Fig. 1 shows a cross-sectional view of the detection system
used in the experiment. The detection system consists of a conventional three-electrode (counter electrode, reference electrode and
working/detecting electrode) electrochemical cell modiﬁed with
additional gating electrodes for applying a gating voltage VG to the
detecting (working) electrode. A piece of 0.5 mm-diameter copper
wire coated with a thin layer of insulator (enamel) was bent to form
a U-shaped structure and was attached on the detecting electrode
close to the exposed area using nonconductive epoxy as the gating electrode. A variable dc power supply was connected between
the gating electrode and the detecting electrode to provide the gating voltage VG . The principle of the ﬁeld-effect enzymatic detector
is described previously (Choi and Yau, 2009). Disks of pyrolytic

graphite (PG) (1 cm × 1 cm) were used as the basic electrode. The PG
electrode was modiﬁed ﬁrst with a thin layer of Naﬁon (Naﬁon 117,
Fluka). The Naﬁon membrane was used to enhance the binding of
the nanotube layer to the PG electrode. Single-walled carbon nanotubes (Carbon Solutions) were dissolved in dimethylformamide.
The nanotube solution was then mixed with 1% glutaraldehyde
solution (Sigma–Aldrich) and a drop of the mixture was placed on
the Naﬁon layer to host the biomarker. The preparation of nanotube
solution and its handling were carried out in a chemical hood in
order to eliminate exposure to aerosol release. A mask was used
to expose a 0.5 mm × 0.5 mm area of the modiﬁed PG electrode.
An 8 �l drop of a solution containing CA-125 (CA-125 ELISA, Signosis), the analyte, was deposited on the exposed area and the
electrode was incubated for 22 h, after which the electrode was
rinsed with de-ionized water. The detecting electrode was formed
by placing a 25 �l drop of solution containing 1 ng/ml of antibody
labeled with HRP (CA-125 ELISA, Signosis) on the exposed area
and incubating the electrode for 45 min. The same antibody concentration (1 ng/ml) was used for the incubation of all electrodes.
The CA 125 antibody was monoclonal and has an afﬁnity constant
of 1.0 × 109 M−1 (Boerman et al., 1990). This protein immobilization method has been used to immobilized other biomarkers (Bollo
et al., 2007; Yu et al., 2005). The antibody was bound to CA-125 due
to immuno-reaction. In Fig. 1, the PG electrode with the multilayers
of materials deposited on it depicts the structure of the detecting electrode. The advantage of immobilizing the antigen on the
electrode without using the primary antibody is that the passage
for electron transfer from the enzyme used to label the secondary
antibody to the electrode is shortened and therefore signal current is increased. Note that without nanotubes the signal would
become weak. This is likely to be due to the better electrical conductivity provided by the nanotubes and the fact that CA 125 was
immobilized on the electrode by being entrapped in the nanotubes.
Voltammetric (cyclic and linear) measurements were made to
obtain the detection signal. A commercial Ag/AgCl (3 M KCl) electrode was used as the reference electrode, and a platinum wire was
used as the counter electrode. The volume of the electrochemical
cell was 1 ml. The cell was driven by a commercial electrochemical
controller (CHI 660C Work Station). A potential scan rate of 50 mV/s
was used in recording voltammograms. Phosphate buffer solution
(PBS, 0.1 M at pH 7) was prepared using de-ionized water (18.2 Mcm). Commercially available hydrogen peroxide (Fisher scientiﬁc,
30% concentration) was diluted to the concentrations used in the
experiment and was stored in plastic containers. All measurements
were made with deaerated PBS at room temperature. Reproducible
results were obtained by repeating each measurement multiple
times.

3. Results and discussion
In carrying out the detection, control experiments have been
performed repeatedly using different types of electrode in order
to avoid possible misinterpretation of the measurement results.
Fig. S1(a) shows several cyclic voltammograms (CVs), which are
used to validate the detection signal of CA-125. The CVs were
obtained in PBS under different electrode conditions. CV1 was
obtained with a modiﬁed PG electrode, upon which CA-125
(200 U/ml) was immobilized. The CA-125-immobilized electrode
was then incubated with the HRP-labeled antibody and then
rinsed with de-ionized water. The electrode now contained the
antigen–antibody immuno-structure on its surface and it is referred
to as the detecting electrode. CV2 was obtained with the detecting
electrode. CV1 is featureless while CV2 shows an increased charging
current and a pair of redox peaks with a formal potential of −0.42 V
and a peak-to-peak separation of 20 mV. Previous works on the

direct electron transfer associated with immobilized HRP show that
the formal potential of this redox process is between −0.5 V and
−0.35 V vs. Ag/AgCl (Ferri et al., 1998; Zhang et al., 2004). Thus, the
redox peaks in CV2 indicate the occurrence of the immunological
binding between CA-125 and its antibody and, therefore, the presence of the antigen–antibody immuno-structure on the electrode.
The small peak-to-peak separation of 20 mV indicates reversible
interfacial electron transfer. The increased charging current is also
consistent with the presence of the antibody on the electrode since
the antibody has increased the effective area of the electrode surface exposed to the solution as shown in Fig. 1. To eliminate the
possibility that residual unbound antibody on the electrode may
generate signal, HRP-labeled antibody (1 ng/ml) was immobilized
on the modiﬁed electrode, the electrode without the presence of
CA-125, and CVs were obtained. CV3, which was obtained with such
electrode, is featureless without the presence of the redox peaks.
The reduced charging current compared to CV2 is consistent with
the absence of CA-125 on the electrode. CV4 shows that the redox
signal becomes weak if carbon nanotubes are not used. Note that
carbon nanotubes rather than carbon powder was used due to the
signiﬁcantly smaller electrical resistivity (Chiodarelli et al., 2011;
Nakazawaa et al., 2004).
Alternatively, the immunological binding was conﬁrmed by
testing the enzymatic activity of HRP. Fig. S1(b) shows four CVs
obtained using a detecting electrode (200 U/ml of CA-125), an
electrode containing the antigen–antibody immuno-structure, in
different concentrations of H2 O2 . The electrode responds to H2 O2
by progressively increasing the cathodic current due to the reduction of H2 O2 catalyzed by HRP. On the contrary, such response
to H2 O2 was not observed using a CA-125-immobilized electrode.
Note that although the CVs show very weak and broadened redox
peaks as indicated by the arrows or no peaks at all, the fact that
the electrode’s cathodic current responds to H2 O2 indicates the
enzymatic activity of HRP as previously observed (Andreu et al.,
2007).
For the detection of CA-125, modiﬁed electrodes that have
been incubated with solutions containing different CA-125 concentrations and subsequently incubated with the same amount of
HRP-labeled antibody (1 ng/ml) were used as detecting electrodes.
The detection signal was obtained by measuring the peak current
of the reduction peak of HRP in the linear voltammograms (LVs) of
different detecting electrodes. Fig. 2(a) shows the LVs of 3 detecting
electrodes, which were incubated with different CA-125 concentrations, obtained in the absence of the gating voltage. The reduction
peak currents were determined using the baseline displayed in the
ﬁgure. The LVs show that as the CA-125 concentration is increased,
the reduction peak current increases. The inset in Fig. 2(a) shows
the CA-125 calibration curve of the detection system obtained with
different detecting electrodes, i.e. 3, 7, 15, 50, 100, 200 U/ml, in the
absence of the gating voltage. The detection limit was estimated
to be 4.9 U/ml, using the signal/noise = 3 method. The curve shows
that the 3 and 7 U/ml data points almost coincide with each other.
The effect of applying VG on the detection signal was studied
and it was found that the reduction-peak current increased as VG
was increased. Fig. 2(b) shows four LVs obtained with a detecting electrode, which has been incubated with 200 U/ml CA-125.
The four CVs were obtained with VG = 0, 0.1, 0.2, 0.3 V, respectively,
and the corresponding peak currents of the reduction peaks are
0.04, 0.3, 0.4, and 0.58 �A as measured using the baseline. Previously, the increase in the signal current of the bio-detector, which
is used in this work, caused by applying VG in the positive polarity
was attributed to the reduction of the height of the tunnel barrier between the active site of the enzyme and the electrode. VG
induces an electric ﬁeld at the enzyme–electrode interface, and
the ﬁeld reduces the effective height of the tunnel barrier, resulting in an increase in the tunnel rate of electrons (Choi and Yau,

Fig. 2. (a) LVs of 3 detecting electrodes, which were immobilized with different CA125 concentrations. The reduction peak currents are indicated using the baseline.
Inset: the calibration curve of detection of CA-125 obtained with different detecting
electrodes. (b) Four LVs obtained with a detecting electrode, which has been incubated with 200 U/ml CA-125. The LVs were obtained with VG = 0, 0.1, 0.2, 0.3 V. (c) The
effect of increasing VG in the negative polarity on the signal current is demonstrated
with a larger 200 U/ml electrode.

2009; Tans et al., 1998). It is believed that the same mechanism is
responsible for the observed increase in the signal current in the
present work. An evidence for this mechanism was observed by
reversing the polarity of VG . A negative VG reverses the direction
of the induced ﬁeld and therefore increases the effective height of
the tunnel barrier (Snow et al., 1988). Fig. 2(c) shows the effect of
increasing VG in the negative polarity on the signal current. The
LVs were obtained with progressively increasing VG in the negative
polarity. The decrease in the signal current appears to be obvious

Fig. 3. (a) The dependences of the ampliﬁcation of signal current on VG for two detecting electrodes immobilized with different CA 125 concentrations. (b) The calibration
curves of the detection system for CA 125 at different values of VG . The curve is plotted using six detecting electrodes immobilized with different CA 125 concentrations,
namely, 3 U/ml, 7 U/ml, 15 U/ml, 50 U/ml, 100 U/ml, and 200 U/ml. (c) Plots of the detection limit and sensitivity of the detection system vs. VG .

with the aid of the baseline. The decrease in the signal supports the
scenario of a modiﬁed tunnel barrier.
The increase of the signal current as shown in Fig. 2(b) indicates
that the detection signal is ampliﬁed by varying VG . Fig. 3(a) shows
the voltage-controlled signal ampliﬁcations observed with two
detecting electrodes incubated with solutions of different CA-125
concentrations. Both curves show that as VG is increased, the signal
current increases. In particular, the ampliﬁcation curves (including those obtained with electrodes incubated with other CA-125
concentrations) show a slightly nonlinear increase as VG is increase
from 0.2 V to 0.3 V. This effect reﬂects the fact that the ampliﬁcation indicated by each curve is caused by the same mechanism,
the modiﬁed tunnel barrier, while the difference between the signal magnitudes of the curves is due to the presence of different
amount of CA-125. The double-arrow sign in Fig. 3(a) indicates that
the ampliﬁcation is controlled reversibly by VG . Note that if VG is
increased beyond 0.3 V, the signal current will show a reversible

inverse dependence on VG , which is explained previously in terms
of reversible re-orientation of the enzyme molecule on the electrode by the induced ﬁeld (Choi and Yau, 2011). In the present case,
ﬁeld-initiated reorientation of the antigen, CA 125, is also a possible
cause for the effect described.
The ampliﬁcation of the detection signal has signiﬁcantly
improved the performance of the detection system. The detection
system’s calibration curves for CA 125 obtained with different values of VG using six detecting electrodes (3, 7, 15, 50, 100, 200 U/ml)
are shown in Fig. 3(b). Curve 1, obtained for VG = 0 V and shown
in Fig. 2(a), is displayed here for comparison. Curves 2–4 were
obtained with different values of VG as indicated in the ﬁgure. All
curves show a linear region for low CA 125 concentrations and a
saturation region at higher concentrations. Since the linear regions
of Curve 1 and Curve 2 are virtually determined by two points,
we discuss curve ﬁtting details for Curve 3 and Curve 4 only. The
regression equation used is y = bx + a, where b is the slope and a is

the y intercept. In particular, y = 0.03078x + 0.41636 was used for
Curve 3 and y = 0.03415x + 0.97441 was used for Curve 4. The correlation coefﬁcients for the two curves are 0.84517 and 0.85783,
respectively.
As stated above, in the absence of VG , the CA 125 detection limit
is 4.9 U/ml. The curves show that as VG is increased, the signal current level increases. In particular, the current span of the linear
range becomes wider accompanied with an increase in its slope.
Comparing the linear range of the curves shows that VG improves
the detection limit, detection resolution and the sensitivity of the
detection system. As the result of increasing VG to 0.3 V, the detection limit is lowered to 0.9 U/ml and the detection system is able
to detect 3 U/ml CA 125. The error bar of the 3 U/ml data point is
clearly separated from that of the 7 U/ml data point. Fig. 3(c) shows
the dependences of the sensitivity and the detection limit of the
detection system on VG . The sensitivity is increased from 1 to about
15 nA/U ml−1 as VG is increased from 0 to 0.3 V. The 5-fold increase
in sensitivity is signiﬁcant since it causes the detection limit to be
lowered from 4.9 to 0.9 U/ml.
4. Conclusions
The present work has demonstrated that the application of the
gating voltage has caused reversible ampliﬁcation of the detection signal of a modiﬁed amperometric immuno-detection system.
The ampliﬁcation has in turn improved the performance of the
detection system in terms of lowering the detection limit, increasing the detection resolution and detection sensitivity. The method
used to prepare the detecting electrodes indicates that the detection approach can be used as a general assay methodology for
biomarkers. The low detection limit obtainable via the application of VG makes the detection method particularly suitable for the
early detection of cancer recurrence. Additionally, the reagentless
approach, in which no mediators or enzyme substrates is required,
is compatible with the requirement for point-of-care approach of
biomarker assay.
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